stock to buy

[www]

ACL: (Pharmaceuticals)

At $33.00, Alcon (ACL) is trading at 20.4x our 2003 EPS
forecast. This P/E multiple is at an 8% discount to
Allergan. The stock is also trading at a
9% discount to the large diversified companies (JNJ and ABT )and at the S&P
multiples when comparing the 2003 P/E multiples. We
believe that Alcon’s valuation is attractive at the current
price.

Cash flow/share:$1.55
Est 5 yrs earning growth:20%
Eps 2001 act.:$1.04
Eps 2002 est.:$1.35
Eps 2003 est.:$1.6

 

[www]

Alcon (ACL) 33.66 +0.66: On March 21, this vision care products manufacturer opened for trading at $33.90. Since then, the stock price has not strayed too far from its debut level. However, the post-IPO quiet period for Alcon expires today, and the stock is trading up 2% in the wake of numerous analyst comments... Salomon Smth Brny initiated coverage with an Outperform rating and price target of $40, believing ACL offers investors a vehicle for stable growth; Goldman Sachs initiated with Market Outperform rating and price target of $41, calling it a "one-stop shop" in Ophthalmology; Merrill Lynch initiated with near-term Strong Buy/long-term Strong Buy rating and price target of $40, believing ACL is well managed and positioned to generate significant growth; Banc of America, CSFB, Lehman Brothers, and SG Cowen initiated with Strong Buy ratings; JP Morgan initiated with a Buy rating. Each firm participated in underwriting this recent IPO

Each firm participated in underwriting this recent IPO
.

 

[www]

abu omar

dear abu omar


should i sell hear?
two dollars profit

 

[www]

3.75
should i sell?

 

[الاســــتا ذ]

Thursday's very Bullish (up) bar with near average volume (90% of average) has no significant technical importance. Thursday's gap up in price suggests further new highs are ahead. Sometimes a stock will pause, or retrace for a few days to fill the gap, before continuing higher.

On a short-term technical basis, the trend is Bullish (up) and the stock is above its 50-day moving average at 34.37 which also confirms its Bullish (up) trend. The stock is slightly overbought according to the Stochastic indicator (72.16).

On a long-term technical basis, the stock (ACL) is trading above its 200-day moving average which implies it is in a positive trend. However, the stock has broken through an important trendline at 39.91 suggesting the next level of support is 36.53. The long-term uptrend has now turned neutral.

The stock will meet resistance at 38.80 and 43.47. If the stock breaks up through resistance at 38.80 then it will probably continue higher to 43.47.

has support at 36.53 and 34.37. If the stock breaks down through support at 36.53 then it will probably continue lower to 34.37

لذلك اقترح عليك بيع نصف الكمية والاحتفاظ بالباقي


مع تمنياتي لك بالتوفيق وحسن اختيارك لهذه الشركة

http://finance.yahoo.com/q?h=1&s=acl&d=t